An IRB Symposium on IND/IDEs
Posted April 23, 2012
Tuesday, May 1, 2012
This three-hour session will feature three speakers: Elizabeth Hohman, MD, Chair and Physician Director of Partners Human Research Committee at Partners, Michele Russell-Einhorn, JD, Senior Director of Office for Human Research Studies at Dana-Faber Cancer Institute, and Matthew Wladkowski, MS, Regulatory Affairs Coordinator at Children’s Boston Hospital. The session will focus on learning when and whether an IND/IDE is required and understanding regulatory requirements associated with IND/IDE studies.
Registration is required. Attendees should RSVP by Friday, April 27, 2012. Please register here: http://cbmi.catalyst.harvard.edu/eventJsf/regulatoryEvent.jsf
If you have trouble registering, please contact Min Kim (E-mail, 617-432-1167).
The Harvard Catalyst Regulatory Knowledge and Support Program helps researchers and institutions navigate clinical & translational researchregulatory processes by minimizing the regulatory burdens through cooperation, interoperability, and access to expertise.